MicroPort Cardiovascular
About
MicroPort Cardiovascular is a division of MicroPort, a global medical technology company based in Shanghai, China. Established in 1998, MicroPort focuses on designing, developing, and manufacturing advanced cardiovascular medical devices. The company is recognized as one of the Medtech Big 100 and emphasizes innovation and clinical validation in interventional cardiology. MicroPort Cardiovascular offers a wide range of products, including drug-eluting stents, percutaneous coronary intervention devices, and transcatheter aortic valve replacement solutions. Their Firehawk Liberty™ stent system is notable for being the first targeted drug-eluting stent to receive CE Mark approval. The company also develops cardiac rhythm management devices such as pacemakers and defibrillators, along with other cardiovascular devices for various heart conditions. With a strong global presence, MicroPort operates R&D and manufacturing facilities in multiple countries, including the US, France, and Germany, and collaborates with healthcare professionals to enhance patient outcomes.
Keywords
Company Information
-
Employees 66
-
Founded 1998
Location
Shanghai, Shanghai, China
